Bioteque Corporation (TPEX: 4107)
Taiwan
· Delayed Price · Currency is TWD 126.00
-1.50 (-1.18%)
Oct 11, 2024, 1:30 PM CST
Bioteque Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,032 | 1,945 | 2,010 | 1,825 | 1,948 | 1,859 | Upgrade
|
| Revenue Growth (YoY) | 2.35% | -3.26% | 10.12% | -6.27% | 4.77% | 15.24% | Upgrade
|
| Cost of Revenue | 1,156 | 1,126 | 1,166 | 1,023 | 1,096 | 1,042 | Upgrade
|
| Gross Profit | 875.66 | 818.94 | 844.54 | 802.87 | 851.75 | 816.96 | Upgrade
|
| Selling, General & Admin | 175.94 | 168.32 | 196.19 | 186.11 | 173.05 | 184.99 | Upgrade
|
| Research & Development | 78.73 | 70.44 | 69.98 | 68.83 | 71.82 | 51.47 | Upgrade
|
| Operating Expenses | 254.66 | 238.76 | 266.17 | 254.94 | 245.04 | 236.47 | Upgrade
|
| Operating Income | 621 | 580.18 | 578.38 | 547.93 | 606.72 | 580.49 | Upgrade
|
| Interest Expense | -10.92 | -11.6 | -4.32 | -1.9 | -1.25 | -1.93 | Upgrade
|
| Interest & Investment Income | 13.27 | 10.97 | 2.14 | 0.73 | 2.31 | 5.97 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.72 | -11.55 | 33.77 | -10.84 | -11.4 | -7.12 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.66 | -1.64 | 3.57 | 5.18 | 5.93 | 32.65 | Upgrade
|
| EBT Excluding Unusual Items | 621.96 | 566.35 | 613.53 | 541.11 | 602.3 | 610.05 | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.13 | 3.16 | 9.65 | -2.91 | -0.51 | 1.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -19.09 | Upgrade
|
| Pretax Income | 628.09 | 569.52 | 623.18 | 538.2 | 601.79 | 592.57 | Upgrade
|
| Income Tax Expense | 126.62 | 116.97 | 129.64 | 106.94 | 113.13 | 128.4 | Upgrade
|
| Net Income | 501.47 | 452.55 | 493.54 | 431.26 | 488.67 | 464.17 | Upgrade
|
| Net Income to Common | 501.47 | 452.55 | 493.54 | 431.26 | 488.67 | 464.17 | Upgrade
|
| Net Income Growth | 11.78% | -8.31% | 14.44% | -11.75% | 5.28% | 14.61% | Upgrade
|
| Shares Outstanding (Basic) | 69 | 69 | 69 | 69 | 69 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 70 | 70 | 70 | 70 | 70 | Upgrade
|
| Shares Change (YoY) | -0.01% | -0.03% | 0.07% | 0.01% | -0.02% | -0.06% | Upgrade
|
| EPS (Basic) | 7.24 | 6.53 | 7.12 | 6.22 | 7.05 | 6.70 | Upgrade
|
| EPS (Diluted) | 7.20 | 6.50 | 7.09 | 6.20 | 7.02 | 6.67 | Upgrade
|
| EPS Growth | 11.59% | -8.32% | 14.35% | -11.68% | 5.25% | 14.80% | Upgrade
|
| Free Cash Flow | 703.82 | 606.62 | -82.25 | -81.63 | 462.72 | 484.02 | Upgrade
|
| Free Cash Flow Per Share | 10.11 | 8.71 | -1.18 | -1.17 | 6.65 | 6.95 | Upgrade
|
| Dividend Per Share | 4.500 | 4.500 | 4.500 | 4.500 | 4.000 | 4.000 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 12.50% | 0% | 0% | Upgrade
|
| Gross Margin | 43.10% | 42.11% | 42.01% | 43.98% | 43.73% | 43.95% | Upgrade
|
| Operating Margin | 30.57% | 29.83% | 28.77% | 30.02% | 31.15% | 31.23% | Upgrade
|
| Profit Margin | 24.68% | 23.27% | 24.55% | 23.62% | 25.09% | 24.97% | Upgrade
|
| Free Cash Flow Margin | 34.64% | 31.19% | -4.09% | -4.47% | 23.76% | 26.04% | Upgrade
|
| EBITDA | 763.47 | 721.32 | 698.87 | 662.61 | 710.97 | 670.93 | Upgrade
|
| EBITDA Margin | 37.58% | 37.09% | 34.76% | 36.30% | 36.50% | 36.09% | Upgrade
|
| D&A For EBITDA | 142.47 | 141.14 | 120.49 | 114.68 | 104.25 | 90.44 | Upgrade
|
| EBIT | 621 | 580.18 | 578.38 | 547.93 | 606.72 | 580.49 | Upgrade
|
| EBIT Margin | 30.57% | 29.83% | 28.77% | 30.02% | 31.15% | 31.23% | Upgrade
|
| Effective Tax Rate | 20.16% | 20.54% | 20.80% | 19.87% | 18.80% | 21.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.